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Abstract
Background: Both anxiety and elevated heart rate (HR) have been implicated in the development of hypertension. The
HyperGen cohort, consisting of siblings with severe and mild hypertension, an age-matched random sample of persons
from the same base populations, and unmedicated adult offspring of the hypertensive siblings (N=1,002 men and 987
women), was analyzed for an association of the angiotenisinogen AGTM235T genotype (TT, MT, MM) with an
endophenotype, heart rate (HR) in high and low anxious groups.
Methodology: The interaction of AGTM genotype with anxiety, which has been independently associated with
hypertension, was investigated adjusting for age, hypertension status, smoking, alcohol consumption, beta blocker
medication, body mass index, physical activity and hours of television viewing (sedentary life style).
Principal Findings: Although there was no main effect of genotype on HR in men or women, high anxious men with the TT
genotype had high HR, whereas high anxious men with the MM genotype had low HR. In women, HR was inversely
associated with anxiety but there was no interaction with genotype.
Conclusion/Significance: The results suggest that high anxiety in men with the TT genotype may increase risk for
hypertension whereas the MM genotype may be protective in high anxious men. This type of gene x environment
interaction may be one reason why genome wide association studies sometimes fail to replicate. The locus may be
important only in combination with certain environmental factors.
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Introduction
Despite a great deal of research on the genetic basis of
hypertension, the results have been disappointing. A genome-wide
association study of 14, 000 cases and 3,000 controls reported that
none of the variants previously associated with hypertension
showed evidence of association [1]. One reason for this may be the
presence of complex gene x environment interactions. The factors
that increase or decrease disease risk of one genotype (e.g.
angiotensinogen), may differ from those affecting another (e.g., the
beta adrenergic receptor Arg38Gly polymorphism). If this is the
case, then interactions may be one reason why relatively few
genetic variants have been consistently found to contribute to
complex diseases at a population level and why replication of
significant findings has been difficult [2]. In addition, contributions
of specific genes may be related to different points in multiple
underlying causal pathways, confounding differentiation at the
phenotypic level (e.g., blood pressure). These issues have led
investigators to begin examining the genetic factors associated with
endophenotypic precursors to the overtsymptoms of disease [2].
An endophenotype is an intermediate phenotype that may be
more directly related to genotype than the clinical phenotype. An
advantage of using endophenotypes is that they help to unravel the
comoplexity of chronic disease by specifying intermediate gene x
environment interactions that contribute to clinical endpoints.
The rennin-angiotensin system and its effects represent an
important endophenotype that has been indicated by several
factors. Plasma renin is involved in the physiology of blood
pressure elevation and responds to environmental factors such as
stress and diet. The renin-angiotensin system plays a central role in
sodium and water homeostasis in the body and contributes to the
maintenance of vascular tone. The AGT gene that encodes
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pathway. Several meta-analyses have reported that individuals
with the TT allele at the site encoding amino acid residue 235 of
the AGT gene (M235T genotype) have a significantly greater risk
for hypertension than those with the MM genotype [3–6]. The
235T-allele has also been associated with CHD even after
controlling for hypertension [7], indicating that it may be related
to CVD risk through multiple pathways. However, the results of
the studies reported so far have not been consistent [8–10].
If a specific genotype is associated with a disease only under
certain circumstances [11], then it may not show significant
association in a genome scan even if it is an important locus [12].
Interactions with other risk factors, when not taken into
consideration, can lead to erroneous or contradictory conclusions.
Environmental factors that influence risk for hypertension
comprise a broad range of factors, e.g., diet, medications,
emotionality such as anxiety and different types of stress, all of
which can modulate gene expression and disease risk. Plasma
renin, one component of the renin-angiotensin system and an
enzyme in the pathway of the potent presser agent, Angiotensin II,
has been reported to increase in response to psychological stress
that also raised blood pressure and heart rate [13]. It has also been
shown to increase in response to stress in mildly hypertensive men
[14] on low salt diets, and to vary depending on whether the
person being stressed has a family history of hypertension [15].
One of the emotional stressors that has been associated with
hypertension, both in longitudinal [16,17,9] and cross-sectional
[18] research is anxiety. However, the findings concerning
association of anxiety and blood pressure are as ambiguous as
those related to the M235T genotype. A possible explanation is
that the association between anxiety and blood pressure is
modified by genetic factors.
A review of the literature indicates that investigating individual
genes or environmental exposures alone gives an incomplete and
sometimes inaccurate depiction of their role in hypertension
etiology [19,20]. Because elevated blood pressure is a systemic
phenomenon, an emergent property that is far downstream from
the function of individual genes, researchers are beginning to
investigate the association of candidate genes with endopheno-
types, or precursors to hypertension to increase the power of
finding an association. According to a recent review, heart rate is a
significant predictor of hypertension, CHD specific and other
causes of mortality [21]. Angiotensin II is also an important stress
hormone [22] that is associated with increases in sympathetic
activity.
The purpose of this paper was to investigate whether
inconsistent results associated with the AGT M235T genotype
might be related to interactions with anxiety. For reasons stated
above and because most of the hypertensives in the HyperGEN
cohort are medicated, we chose as our outcome measure, the
endophenotype, heart rate. Due to gender differences in
physiology, men and women were analyzed separately.
Results
A total of 2195 Caucasian subjects (1,090 men, 1,105 women)
had complete data on both anxiety and AGTM235T genotype.
The number of MM homozygotes was 315 in men and 284 in
women. There were 261 TT homozygotes in men and 249 in
women, and 514 MT heterozygotes in men and 572 in women.
The association between heart rate and blood pressure was
significant. The average heart rate in men with hypertension was
2.7 beats/minute faster than those without hypertension
(p=0.005) and in women with hypertension average heart rate
was 2.5 beats/minute faster than in normotensive women
(p,0.004). Heart rate was also significantly correlated with plasma
renin (r=0.12, p=0.0006).
The main effect of genotype on heart rate (Table 1) was not
significant in either men (p=0.86) or women (P=0.50).
The results for anxiety can be seen in Table 2. They show that,
when examined in isolation, there is a significant association of
high anxiety with lower heart rate only in women. There is no
main effect of anxiety in men.
The interaction between M235T genotype and anxiety was
significant in men but not in women (Table 3 and Figure 1). In
men with high anxiety, the TT genotype had the highest heart rate
and the MM homozygote the lowest. Average heart rate for the
MT genotype fell between the average heart rates of the genotypes
for the two homozygotes. These differences were significant
despite the adjustment for beta blocker medication. No such
pattern was present among women.
Discussion
After adjusting for confounders, this population based study
revealed a lack of association between AGT M235T genotype and
heart rate in men and women when analyzed in the absence of
data on anxiety. However, when the interaction of genotype with
anxiety was examined, significant findings emerged. Among men
with high anxiety, the TT genotype had the highest heart rate and
the MM genotype the lowest. Given that almost all hypertensives
are medicated, it is not surprising that the absolute values of heart
rate are not high. However, the significant variation of heart rate
by genotype in men in the presence of anxiety indicates that the
TT genotype would be more at risk in the presence of anxiety than
either the MM homozygote or the heterzygote. No such
interaction was observed in women. The inverse association
between HR and anxiety in women suggests that there are other
environmental factors involved that were not investigated in this
Table 1. Within gender mean heart rates (beats/minutes) by
genotype.
Sex AGT M235T Polymorphism
MM MT TT P-value
Men No. Subjects 313 488 201
Heart rate 65.1 64.8 65.3 P=0.86
Women No. Subjects 283 548 156
Heart rate 69.1 69.6 70.2 P=0.50
doi:10.1371/journal.pone.0013353.t001
Table 2. Mean heart rate (beats/minute) by anxiety group in
women and men.
Sex Anxiety
Low High P-value
Men No. Subjects 454 548
Heart rate 64.8 65.3 0.51
Women No. Subjects 426 561
Heart rate 70.4 68.9 0.02
doi:10.1371/journal.pone.0013353.t002
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masked by gene x environment (in this case, anxiety) interactions,
and may lead to false negative conclusions about genetic factors
related to pathophysiologic mechanisms.
The widespread inconsistency reported in many candidate gene
studies [23,24] has variously been attributed to factors such as
epistasis, population drift, population stratification, and genetic
diversity. More than 50 genes associated with heart rhythm have
been identified in mice [25], and differences by sex and strain of
animals have also been found [26]. In the HyperGEN Study, Wilk
et al [27] found that the proportion of variance in resting heart
rate explained by genetic factors was 24% in African-Americans
and 27% for whites. Given this evidence for epistasis in the
endophenotype of heart rate and given the number of endophe-
notypes that may be involved in sustained blood pressure
elevation, it is little wonder that genome wide association studies
of hypertension have been difficult to replicate. In addition
to epistasis, the field of epigenetics has also taught us that gene
expression can be up and down regulated by cues from the micro-
environment, which means that one and the same gene may be
associated with different phenotypes depending on the environ-
mental influences to which it is being exposed at the time of
measurement. The current study seems to verify the importance of
gene x environment interactions in phenotypic expression. Rather
than assuming that the candidate gene is not relevant because the
main effect is not significant, we should be asking whether there are
particular circumstances under which this gene explains a
significant amount of the variance and others where it does not.
The size of the HyperGen data set provides one of the few well
powered opportunities to examine interactions separately by gender.
The present data suggest that using endophenotypes (here, heart rate)
and evaluating interactions of genetic and environmental factors
(here, anxiety) provides a valuable way to investigate and understand
the complexities of pathophysiological mechanisms that may underlie
components of hypertension, and may provide clues for the
development of improved treatments for this complex disorder.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Boards of the participating studies. All
patients provided written informed consent for the collection of
samples and subsequent analysis. Study design and methods can
be found in: Williams RR, Rao DC, Ellison RC, Arnett DK, Heiss
G, Oberma A, Eckfeldt JH, Leppert MF, Province MA, Mockrin
SC, Hunt SC. NHLBI Family blood Pressure Program: Method-
Figure 1. Heart Rate by Genotype and Anxiety Level in Men.
doi:10.1371/journal.pone.0013353.g001
Table 3. Mean heart rate (beats/minute) by Anxiety group
and Agtm235t genotype in women and men.
Sex Anxiety AGT M235T Polymorphism
MM MT TT P-value
Men Low 66.8 (n=143) 64.0 (n=219) 63.3 (n=92) 0.003
High 63.7 (n=170) 65.4 (n=269) 66.9 (n=109)
Women Low 70.2 (n=131) 70.1 (n=244) 71.3 (n=51) 0.78
High 68.1 (n=152) 69.0 (n=304) 69.3 (n=105)
doi:10.1371/journal.pone.0013353.t003
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200;10:389–400. The HyperGEN Study was reviewed by the
Institutional Review Boards of each site: The Institutional Review
Board of the University of Alabama at Birmingham Medical
School, the Institutional Review Board of Boston University
School of Medicine which uses INSPIR, the Integrated Network
for Subject Protection in Research, the Institutional Review Board
of the University of Minnesota Medical School, the Institutional
Review Board of the University of Utah Medical School, the
Institutional Review Board of the University of Minnesota, and the
Institutional Review Board of the University of North Carolina.’’
Cohort
The HyperGen collaboration involves four field centers of the
National Heart, Lung, and Blood Institute Family Heart Study
(Framingham, Minneapolis, Salt Lake City, and Forsyth County)
and a fifth field center in Birmingham, Alabama. There were three
groups of participants: siblings with severe and mild hypertension,
an age-matched random sample of persons from the same base
populations, and unmedicated adult offspring of the hypertensive
siblings. The addition of this latter group permits phenotypic
characterization of genetic polymorphisms associated with hyper-
tension and intermediate phenotypes [28]. The present analyses
are based on data from all three groups.
Genome Analyses
DNA extraction and purification was done with sodium
dodecylsulfate cell lysis followed by salt precipitation for protein
removal, using commercial Puregene reagents (Gentra System,
Inc., Minneapolis, MN). The distribution of allelic variants
differed markedly by ethnicity with participants with African-
American ancestry having a higher distribution of the TT
genotype than participants with Caucasian ancestry. Since the
number of African American subjects were relatively small
(n=208), we limited the analysis to the Caucasian participants
only. Genome scans were performed by the Marshfield Mamma-
lian Genotyping Service and the M235T AGT polymorphisms
were typed in 1,960 and 2,627 women.
Heart Rate
Heart rate was measured with a Dinamap Blood Pressure cuff
model 1846 SX/P simultaneously with blood pressure. Six
consecutive measurements were made, three on the left and three
on the right arm. The participant rested for 5 minutes before
measurement and for 30 seconds between measurements. The
measure used in these analyses as the phenotype was the average
HR from all six measurements.
Anxiety and covariates
Anxiety was measured with the Spielberger trait anxiety scale
[29]. This measure was chosen because it represents a stable trait
rather than a transient reaction. For the purposes of these analyses,
it was dichotomized into high and low anxiety groups using the
upper and lower tertiles, rather than a median split, to reduce the
possibility of misclassification. The covariates were age, hyperten-
sion status, smoking, alcohol consumption (ml per week), hours of
television viewing (a proxy for sedentary life style), body mass
index, beta blocker use (which can affect HR), and physical
activity (number of blocks walked per day).
Statistical Analyses
The number of genotyped individuals with measures of anxiety
and all covariates was 987 women and 1002 men. Generalized
estimating equations were used to obtain the regression coefficients
and adjusted means [30,31], specifying family as the clustering
variable and adjusting for the dependence of data within families.
All analyses were conducted using the software package SAS
version 9.1 (SAS Institute, Cary, North Carolina). The statistical
significance critera was a=0.05.
Because of physiological differences in men and women that
influence cardiac outcomes and because of differences in average
heart rate in men and women in this cohort, analyses were
performed separately by gender. First sex-specific associations
between anxiety and heart rate and between AGTM235T
genotype (MM, MT, TT) and heart rate were calculated, adjusting
the regressions for beta blocker medication, age, body mass index,
smoking status, alcohol consumption, number of blocks walked per
day, and hours of television watched. We then regressed heart rate
on AGTM235T genotype (MM, MT, TT), anxiety score and the
interaction of genotype and anxiety score in gender specific models
to investigate whether the association between anxiety and heart
rate would be modified by AGTM235T genotype adjusting for the
same covariates.
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